Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

nts who discontinued study therapy in ETV-027, and subsequently restarted treatment in rollover study ETV-901, with a greater than 60 day gap between end of treatment in study ETV-027 and start of treatment in study ETV-901.

    -- ETV-027 compared 0.5 mg of BARACLUDE vs. 100 mg of lamivudine in
nucleoside-naive chronic HBeAg-negative chronic hepatitis B patients.
-- Rollover study ETV-901 was established as an open-label, follow-up
protocol for patients in phase II and III studies of BARACLUDE.
-- Due to ongoing blinding of study ETV-027, most patients retreated in
ETV-901 initially received a combination of 1 mg of BARACLUDE plus 100
mg of lamivudine, and were subsequently switched to 1 mg of BARACLUDE
monotherapy.

The analysis cohort was defined regardless of treatment response at the end of dosing in study ETV-027, and independent of virologic or ALT measurements at the start of dosing in study ETV-901. During off-treatment follow-up, the majority of patients had recurrent levels of hepatitis B virus in the blood (viremia) and increases in ALT.

    Data Results
At the end of dosing for study ETV-027:
-- 94 percent (n=93/99) of the re-treatment cohort had undetectable viral
load
-- 78 percent (n=77/99) had ALT normalization
At entry into ETV-901:
-- Four percent (n=4/99) of patients had undetectable viral load
-- Eight percent (n=8/97) of patients had ALT normalization
Following re-treatment in study ETV-901:
-- 93 percent (n=82/88) of patients had undetectable viral load (HBV DNA
<300 copies/mL) by week 48 of re-treatment with BARACLUDE
-- 83 percent (n=79/95) of patients had ALT normalization (ALT less than
or equal to 1 times the upper limit of normal) by week 48 of re-
treatment BARACLUDE
Adverse events in study ETV-027/901 re-treatment cohort:
-- 67 percent (n=66/99) of patients experienced an adverse event. The most
common adverse events occurring in greater than ten percent of patients
were abdominal pain, fa
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:11/21/2014)... Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... previously announced underwritten public offering of $50,000,000 of shares ... registration statement. The offering will consist of 49,751,244 shares ... $1.005 per share.  Lexicon has also granted the underwriters ... shares of common stock.  All of the shares in ...
(Date:11/18/2014)... MOUNT LAUREL, N.J. , Nov. 18, 2014 ... more than 230,000 American women this year who ... Manager Certification® today announced new resources for case ... cancer—stages 4 and 5—to navigate the myriad physical, ... territory. The resources are available at no cost ...
(Date:11/18/2014)... , Nov. 18, 2014 SynCardia Systems, ... the Year Award for Small Companies presented by the ... Authority. The 11th annual Governor,s Celebration of ... Arizona . Arizona ... the awards ceremony. SynCardia was honored for its Freedom® ...
Breaking Medicine Technology:Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3
(Date:11/21/2014)... Lauderdale, FL (PRWEB) November 21, 2014 Body ... services announced that it accepts Spafinder massage gift cards ... and in room hotel massage in all service areas including ... you don't have to go to the spa at all ... Owner and Founder of Body Well. "We may not be ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Scientists say they,ve mapped the genome ... a British man,s brain, in hopes it might help others ... in the journal Genome Biology , the tapeworm was ... Chinese ethnicity. "This infection is so rare worldwide and ... diagnosed ... until the worm was pulled out from the ...
(Date:11/21/2014)... Mo (PRWEB) November 21, 2014 ... the Get With The Guidelines®–Heart Failure Gold-Plus Quality ... outlined by the American Heart Association/American College of ... heart failure patients. , Get With The Guidelines–Heart ... hospital teams provide the most up-to-date, research-based guidelines ...
(Date:11/21/2014)... November 21, 2014 Recently, VogueQueen ... launched a wedding dress promotion for the coming holiday ... a special offer when checking out. , The beach ... 2014. The customers like the designs for the premium ... would not only be good for the environment, they ...
(Date:11/21/2014)... Lauderdale, Florida (PRWEB) November 21, 2014 ... for chronic headaches and other jaw-related symptoms, ... patients seeking relief from chronic head pain, neck pain, ... , “This year we have seen a 52% ... treated. Our network of over 300 doctors and their ...
Breaking Medicine News(10 mins):Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2Health News:National Rise In Patients Seeking Headache Relief 2
... shows that HIV patients are more willing to consider ... . ,Initial results from the OpenMind ... patients' and physicians' perceptions of HIV care in treatment-experienced ... findings are anticipated to help physicians implement improved care ...
... be considered as an important breakthrough in our still ... a new gene linked to major mental illness // ... known to increase the risk of schizophrenia and depression. ... Glasgow, together with scientists from the pharmaceutical company Merck, ...
... resistance rates of the HIV virus in the UK ... Day that is to be celebrated on December 1st. ... raising a possibility of a second wave epidemic of ... in the management of AIDS victims. The currently available ...
... been a mixed response from private professional colleges regarding ... admission into medical and engineering colleges // . Few ... should be based on higher secondary marks alone. ... colleges have the right to decide upon admission on ...
... reached after a comprehensive study conducted by the scientists ... entered data on climate-sensitive diseases // into mapping software ... that the worst affected by the climate change are ... phenomenon in any way. The study's lead author, Jonathan ...
... infected at least five people working in a slaughterhouse, an ... infections came to light after official confirmation that about 30 ... anthrax recently. ,The local health office earlier ... discovered that the cattle they had slaughtered were infected with ...
Cached Medicine News:Health News:Patients More Willing To Use Self-Injectable HIV Therapy Than Anticipated 2Health News:A Step Towards Unraveling The Schizophrenia And Depression Mystery 2Health News:Mixed Opinion Regarding Common Medical And Engineering Entrance Test 2Health News:Five People Treated For Anthrax In Indonesia 2
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
Inquire...
... is precision, ergonomics, and value!, ... with soft non-slip, contoured handle , ... light plunger spring action , Completely ... without the need for recalibration , ...
Medicine Products: